Advertisement
UK markets closed
  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     
  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     
  • AIM

    789.87
    +6.17 (+0.79%)
     
  • GBP/EUR

    1.1628
    +0.0017 (+0.15%)
     
  • GBP/USD

    1.2528
    +0.0004 (+0.03%)
     
  • Bitcoin GBP

    48,189.04
    -1,251.23 (-2.53%)
     
  • CMC Crypto 200

    1,254.57
    -103.44 (-7.62%)
     
  • S&P 500

    5,218.52
    +4.44 (+0.09%)
     
  • DOW

    39,475.12
    +87.36 (+0.22%)
     
  • CRUDE OIL

    78.32
    -0.94 (-1.19%)
     
  • GOLD FUTURES

    2,375.60
    +35.30 (+1.51%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     
  • DAX

    18,772.85
    +86.25 (+0.46%)
     
  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     

Top Ranked Growth Stocks to Buy for January 29th

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, January 29th:

Legg Mason, Inc. (LM): This asset management holding company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.7% over the last 60 days.

Legg Mason, Inc. Price and Consensus

Legg Mason, Inc. Price and Consensus
Legg Mason, Inc. Price and Consensus

Legg Mason, Inc. price-consensus-chart | Legg Mason, Inc. Quote

Legg Mason has a PEG ratio of 0.81, compared with 1.26 for the industry. The company possesses a Growth Score of B.

Legg Mason, Inc. PEG Ratio (TTM)

Legg Mason, Inc. PEG Ratio (TTM)
Legg Mason, Inc. PEG Ratio (TTM)

Legg Mason, Inc. peg-ratio-ttm | Legg Mason, Inc. Quote

ADVERTISEMENT

Alexion Pharmaceuticals, Inc. (ALXN): This company that develops and commercializes various therapeutic products, carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.9% over the last 60 days.

Alexion Pharmaceuticals, Inc. Price and Consensus

Alexion Pharmaceuticals, Inc. Price and Consensus
Alexion Pharmaceuticals, Inc. Price and Consensus

Alexion Pharmaceuticals, Inc. price-consensus-chart | Alexion Pharmaceuticals, Inc. Quote

Alexion has a PEG ratio of 0.63, compared with 0.85 for the industry. The company possesses a Growth Score of B.

Alexion Pharmaceuticals, Inc. PEG Ratio (TTM)

Alexion Pharmaceuticals, Inc. PEG Ratio (TTM)
Alexion Pharmaceuticals, Inc. PEG Ratio (TTM)

Alexion Pharmaceuticals, Inc. peg-ratio-ttm | Alexion Pharmaceuticals, Inc. Quote

Delta Air Lines, Inc. (DAL): This provider of scheduled air transportation for passengers and cargo, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.3% over the last 60 days.

Delta Air Lines, Inc. Price and Consensus

Delta Air Lines, Inc. Price and Consensus
Delta Air Lines, Inc. Price and Consensus

Delta Air Lines, Inc. price-consensus-chart | Delta Air Lines, Inc. Quote

Delta Air Lines has a PEG ratio of 0.56, compared with 1.27 for the industry. The company possesses a Growth Score of A.

Delta Air Lines, Inc. PEG Ratio (TTM)

Delta Air Lines, Inc. PEG Ratio (TTM)
Delta Air Lines, Inc. PEG Ratio (TTM)

Delta Air Lines, Inc. peg-ratio-ttm | Delta Air Lines, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Growth score and how it is calculated here.    

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Legg Mason, Inc. (LM) : Free Stock Analysis Report
 
Delta Air Lines, Inc. (DAL) : Free Stock Analysis Report
 
Alexion Pharmaceuticals, Inc. (ALXN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.